Tissue remodeling in chronic rhinosinusitis

Current Opinion in Allergy and Clinical Immunology

Volumn 11, Issue 1, 2011, Pages 8-11

  Van Bruaene, Nicholas ^a   Bachert, Claus ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Collagen; matrix metalloproteinase; transforming growth factor beta

Indexed keywords

ADAM 33 PROTEIN; ADAM PROTEIN; CLARITHROMYCIN; DOXYCYCLINE; GELATINASE B; MACROLIDE; MATRIX METALLOPROTEINASE; METHYLPREDNISOLONE; STEROID; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; ARTICLE; CHRONIC RHINOSINUSITIS; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LOW DRUG DOSE; NOSE; NOSE MUCOSA; NOSE POLYP; PARANASAL MUCOSA; PRIORITY JOURNAL; RHINOSINUSITIS; TISSUE REGENERATION;

ADAM PROTEINS; CHRONIC DISEASE; COLLAGEN; EXTRACELLULAR MATRIX; HUMANS; INFLAMMATION MEDIATORS; MATRIX METALLOPROTEINASES; NASAL POLYPS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET-DERIVED GROWTH FACTOR; RHINITIS; SINUSITIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 78650837681     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32834233ef     Document Type: Article

References (38)

1. Bousquet J, Chanez P, Lacoste JY, et al. Asthma: a disease remodeling the airways. Allergy 1992; 47:3-11.
2. Bai TR. Evidence for airway remodeling in chronic asthma. Curr Opin Allergy Clin Immunol 2010; 10:82-86.
3. Bai TR, Knight DA. Structural changes in the airways in asthma: observations and consequences. Clin Sci (Lond) 2005; 108:463-477.
4. Van Cauwenberge P, Watelet JB. Epidemiology of chronic rhinosinusitis. Thorax 2000; 55 (Suppl 2):S20-S21.
5. Fokkens W, Lund V, Bachert C, et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy 2005; 60:583-601. (Pubitemid 40562464)
6. Van Bruaene N, Perez-Novo CA, Basinski TM, et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol 2008; 121:1435-1441, 1441.e1-e3.
7. Huvenne W, Van Bruaene N, Zhang N, et al. Chronic rhinosinusitis with and without nasal polyps: what is the difference? Curr Allergy Asthma Rep 2009; 9:213-220.
8. van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006; 61:1280-1289.
9. Bachert C, Gevaert P, Holtappels G, et al. Nasal polyposis: from cytokines to growth. Am J Rhinol 2000; 14:279-290.
10. Van Bruaene N, Derycke L, Perez-Novo CA, et al. TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol 2009; 124:253-9, 259.e1-259.e2.
11. Stoop AE, van der Heijden HA, Biewenga J, van der BS. Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study. J Allergy Clin Immunol 1993; 91:616-622.
12. Hiraide F, Kakoi H. Histochemical study on innervation of glands and blood vessels in nasal polyps. Acta Otolaryngol Suppl 1986; 430:5-11.
13. Kakoi H, Hiraide F. A histological study of formation and growth of nasal polyps. Acta Otolaryngol 1987; 103:137-144.
14. Pawankar R, Nonaka M. Inflammatory mechanisms and remodeling in chronic rhinosinusitis and nasal polyps. Curr Allergy Asthma Rep 2007; 7:202-208.
15. Li X, Meng J, Qiao X, et al. Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis. J Allergy Clin Immunol 2010; 125:1061-1068.
16. Zhang N, Liu S, Lin P, et al. Remodeling and inflammation in Chinese versus white patients with chronic rhinosinusitis. J Allergy Clin Immunol 2010; 125:507-508.
17. Wallwork B, Coman W, Mackay-Sim A, Cervin A. Effect of clarithromycin on nuclear factor-kappa B and transforming growth factor-beta in chronic rhinosinusitis. Laryngoscope 2004; 114:286-290.
18. Greenlee KJ, Werb Z, Kheradmand F. Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev 2007; 87:69-98.
19. Gueders MM, Foidart JM, Noel A, Cataldo DD. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur J Pharmacol 2006; 533:133-144.
20. Kelly EA, Jarjour NN. Role of matrix metalloproteinases in asthma. Curr Opin Pulm Med 2003; 9:28-33.
21. ParksWC, Shapiro SD. Matrix metalloproteinases in lung biology. Respir Res 2001; 2:10-19.
22. Lee YM, Kim SS, Kim HA, et al. Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1. J Korean Med Sci 2003; 18:97-102.
23. Kostamo K, Tervahartiala T, Sorsa T, et al. Metalloproteinase function in chronic rhinosinusitis with nasal polyposis. Laryngoscope 2007; 117:638-643.
24. Lechapt-Zalcman E, Coste A, d'Ortho MP, et al. Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 2001; 193:233-241.
25. Watelet JB, Bachert C, Claeys C, Van Cauwenberge P. Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy 2004; 59:54-60.
26. Chen YS, Langhammer T, Westhofen M, Lorenzen J. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps. Allergy 2007; 62:66-72.
27. Watelet JB, Bachert C, Claeys C, Van Cauwenberge P. Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy 2004; 59:54-60.
28. Li X, Meng J, Qiao X, et al. Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis. J Allergy Clin Immunol 2010; 125:1061-1068.
29. Wang LF, Chien CY, Tai CF, et al. Matrix metalloproteinase-9 gene polymorphisms in nasal polyposis. BMC Med Genet 2010; 11:85.
30. Wang LF, Chien CY, Kuo WR, et al. Matrix metalloproteinase-2 gene polymorphisms in nasal polyps. Arch Otolaryngol Head Neck Surg 2008; 134:852-856.
31. van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol 2010; 125:1069-1076.
32. Kanai K, Asano K, Hisamitsu T, Suzaki H. Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro. Eur Respir J 2004; 23:671-678. (Pubitemid 38618134)
33. Watelet JB, Demetter P, Claeys C, et al. Neutrophil-derived metalloproteinase-9 predicts healing quality after sinus surgery. Laryngoscope 2005; 115:56-61.
34. Huvenne W, Zhang N, Tijsma E, et al. Pilot study using doxycycline-releasing stents to ameliorate postoperative healing quality after sinus surgery. Wound Repair Regen 2008; 16:757-767.
35. Erbek SS, Erinanc H, Erbek S, et al. Expression of a disintegrin and metalloproteinaseprotein in nasal polyposis: an immunohistochemical study. Am J Rhinol Allergy 2010; 24:79-82.
36. Kouzaki H, Seno S, Fukui J, et al. Role of platelet-derived growth factor in airway remodeling in rhinosinusitis. Am J Rhinol Allergy 2009; 23:273-280.
37. van Zele T, Coppieters F, Gevaert P, et al. Local complement activation in nasal polyposis. Laryngoscope 2009; 119:1753-1758.
38. Sejima T. The expression of fibrinolytic components in chronic paranasal sinus disease. American J Rhinol Allergy 25, 1-6, 2011, article in press.